SCHEMBL24064573

SCHEMBL24064573

O=C(NCCOCCOCCOCCOC(=O)c1cccnc1)Oc1ccc(CCc2cc(OC(=O)NCCOCCOCCOCCOC(=O)c3cccnc3)cc(OC(=O)NCCOCCOCCOCCOC(=O)c3cccnc3)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
KMT2A Q03164 8/20 0.46
MAPT P10636 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 5/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 1/20 0.43
POLB P06746 1/20 0.43
CYP3A4 P08684 1/20 0.43
PKM P14618 1/20 0.43
KDM4E B2RXH2 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21946320 0.87 KMT2A (0.46) L3MBTL1KMT2AMAPTALDH1A1MEN1
SCHEMBL21946327 0.84 KMT2A (0.48) KMT2AMAPTALDH1A1MEN1SMN1; SMN2
SCHEMBL21946324 0.83 KMT2A (0.45) L3MBTL1KMT2AMAPTALDH1A1MEN1
SCHEMBL24064578 0.82 KMT2A (0.47) L3MBTL1KMT2AMAPTALDH1A1MEN1
SCHEMBL24064580 0.77 L3MBTL1 (0.52) L3MBTL1KMT2AMAPTALDH1A1MEN1
SCHEMBL24064584 0.77 L3MBTL1 (0.52) L3MBTL1KMT2AMAPTALDH1A1MEN1
SCHEMBL21946325 0.73 KMT2A (0.47) KMT2AMAPTALDH1A1MEN1SMN1; SMN2
SCHEMBL24064581 0.72 KMT2A (0.52) KMT2AMAPTMEN1USP2LMNA
SCHEMBL25009812 0.72 L3MBTL1 (0.76) L3MBTL1KMT2AMAPTALDH1A1MEN1
SCHEMBL30556174 0.72 L3MBTL1 (0.76) L3MBTL1KMT2AMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210371446-A1 SIRT1 ACTIVATING COMPOUNDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210371446-A1 SIRT1 ACTIVATING COMPOUNDS SIRT1, SIRT2, SIRT3 L3MBTL1 2991/4885KMT2A 458/4885MAPT 727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.